Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
Phase 1
Completed
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Seasons Biotechnology (Taizhou) Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT05417087
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
Phase 1
Completed
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Seasons Biotechnology (Taizhou) Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT05416957
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
Single Dose Study to Evaluate Dose-proportionality of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
Phase 1
Completed
- Conditions
- Major Depressive Disorder (MDD
- Interventions
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Seasons Biotechnology (Taizhou) Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT05416762
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
News
No news found